Molecular Mechanisms of β-Lactam Resistance Mediated by AmpC Hyperproduction inPseudomonas aeruginosaClinical Strains
Open Access
- 1 November 2005
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (11), 4733-4738
- https://doi.org/10.1128/aac.49.11.4733-4738.2005
Abstract
The molecular mechanisms of β-lactam resistance mediated by AmpC hyperproduction in natural strains of Pseudomonas aeruginosa were investigated in a collection of 10 isogenic, ceftazidime-susceptible and -resistant pairs of isolates, each sequentially recovered from a different intensive care unit patient treated with β-lactams. All 10 ceftazidime-resistant mutants hyperproduced AmpC (β-lactamase activities were 12- to 657-fold higher than those of the parent strains), but none of them harbored mutations in ampR or the ampC-ampR intergenic region. On the other hand, six of them harbored inactivating mutations in ampD: four contained frameshift mutations, one had a C→T mutation, creating a premature stop codon, and finally, one had a large deletion, including the complete ampDE region. Complementation studies revealed that only three of the six ampD mutants could be fully transcomplemented with either ampD- or ampDE-harboring plasmids, whereas one of them could be transcomplemented only with ampDE and two of them (including the mutant with the deletion of the ampDE region and one with an ampD frameshift mutation leading to an ampDE-fused open reading frame) could not be fully transcomplemented with any of the plasmids. Finally, one of the four mutants with no mutations in ampD could be transcomplemented, but only with ampDE. Although the inactivation of AmpD is found to be the most frequent mechanism of AmpC hyperproduction in clinical strains, our findings suggest that for certain types of mutations, AmpE plays an indirect role in resistance and that there are other unknown genes involved in AmpC hyperproduction, with at least one of them apparently located close to the ampDE operon.Keywords
This publication has 40 references indexed in Scilit:
- Lack of Association between Hypermutation and Antibiotic Resistance Development inPseudomonas aeruginosaIsolates from Intensive Care Unit PatientsAntimicrobial Agents and Chemotherapy, 2004
- Constitutive High Expression of Chromosomal β-Lactamase in Pseudomonas aeruginosa Caused by a New Insertion Sequence (IS 1669 ) Located in ampDAntimicrobial Agents and Chemotherapy, 2002
- ampR Gene Mutations That Greatly Increase Class C β-Lactamase Activity in Enterobacter cloacaeAntimicrobial Agents and Chemotherapy, 2000
- β-Lactamase Induction in Gram-Negative Bacteria Is Intimately Linked to Peptidoglycan RecyclingMicrobial Drug Resistance, 1995
- Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosaGene, 1994
- Investigation of thePseudomonas aeruginosa ampRgene and its role at the chromosomalampCβ-lactamase promoterFEMS Microbiology Letters, 1993
- Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed β-lactamase producing strainsJournal of Antimicrobial Chemotherapy, 1990
- Response of chemostat cultures of Pseudomonas aeruginosa to carbapenems and other β-lactamsJournal of Antimicrobial Chemotherapy, 1990
- Regulation of enterobacterial cephalosporinase production: the role of a membrane‐bound sensory transducerMolecular Microbiology, 1989
- Clinical significance of beta-lactamase induction and stable derepression in gram-negative rodsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987